期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
ACEI与长效CCB对高血压脑卒中二级预防的效果分析 被引量:10
1
作者 刘国韬 王艾 +5 位作者 刘小红 严利南 曾广民 欧阳学逸 刘世芳 邓东明 《中国当代医药》 2015年第12期102-105,共4页
目的:探讨ACEI与长效CCB对高血压合并脑卒中二级预防的效果。方法回顾性分析2009年6月~2014年6月社区健康档案中高血压合并脑卒中存活跃2个月的患者863例,以ACEI为降压基础治疗的408例,长效CCB为降压基础治疗的455例,主要观察脑卒... 目的:探讨ACEI与长效CCB对高血压合并脑卒中二级预防的效果。方法回顾性分析2009年6月~2014年6月社区健康档案中高血压合并脑卒中存活跃2个月的患者863例,以ACEI为降压基础治疗的408例,长效CCB为降压基础治疗的455例,主要观察脑卒中的复发、脑卒中死亡、心肌梗死发生及死亡、总死亡等,观察时间6~70个月,平均39个月。结果两组患者血压下降幅度比较差异无统计学意义(P〉0.05);两组危险因素干预情况比较差异无统计学意义(P〉0.05);ACEI组联合利尿剂的患者多于CCB组,差异有统计学意义(P〈0.05);两组≥2种联合用药率相比,差异无统计学意义(P〉0.05);ACEI组与CCB组所有脑卒中复发分别为111例(27.2%)、107例(23.5%),差异有统计学意义(P〈0.05);两组其他心血管事件发生率比较,差异无统计学意义(P〉0.05)。结论降压药对高血压合并脑卒中二级预防的效果与脑卒中一级预防相同,长效CCB优于ACEI。 展开更多
关键词 高血压 脑卒中 二级预防 规范治疗 长效钙拮抗剂 血管紧张素转换酶抑制剂
下载PDF
Etiological characteristics and treatment of tardive dyskinesia
2
作者 Zhe Li Xueli Sun Che Zhou 《Neural Regeneration Research》 SCIE CAS CSCD 2006年第6期549-552,共4页
OBJECTIVE : The pathogenesis of tardive dyskinesia (TD) is complicated and uncertain, Thus, there is not any effective treatment for it. The psychiatrists pay more and more attention to TD, which lasts for a long t... OBJECTIVE : The pathogenesis of tardive dyskinesia (TD) is complicated and uncertain, Thus, there is not any effective treatment for it. The psychiatrists pay more and more attention to TD, which lasts for a long time and is difficult to treat. DATA SOURCES: A computer-based online search of Medline database was undertaken to identify articles about the feature of etiology and the progression of treatment for TD published in English by using the keywords of "rD, etiology, pathogenesis" and "TD, therapy, drug treatment". Meanwhile, Chinese articles about the feature of etiology and the progression of treatment for TD were searched in Wanfang database and China journal full-text database, and the keywords were "TD, etiology, pathogenesis" and "TD, therapy, drug Treatment" in Chinese. STUDY SELECTION: Articles met the following inclusion criteria were selected in this paper. Inclusion criteria: (1) Researches of randomized blind control design, before and after control design and retrospective. (2) Researches of the feature of etiology and the progression of treatment for TD. Exclusion criteria: the repetitive researches and individual reports. DATA EXTRACTION : Totally 65 articles related the feature of etiology and the progression of treatment for TD of randomized blind control design, before and after control design and retrospective studies were collected, and 53 of them were accorded with the inclusion criteria. Of the 12 excluded ones, 8 were concerning with genetics, 4 were repetitive researches. DATA SYNTHESIS : The feature of etiology for TD includes:(1) Hypothesis of dopamine receptor super-sensitivity: The dopamine receptor is persistently blocked, so it will result in functional disorder in CNS, and then TD may take place. (2)) Hypothesis of neuronal degeneration: The concentration of aminosuccinic acid and glutamic acid will increase after the antipsychotic used for a long time and this will result in neuronal degeneration through glutamic acid receptor in the postsynaptic membrane; meanwhile with free radical, the nerve cells of corpus striatum may degenerate and become necrosis. (3) Sex and age: The females and gerontal patients are liability to the TD disease. It is may related to the lower estrogen. (4) Molecule heredity: TD may association with the dopamine and 5-HT receptor gene polymorphism. (5) Other theories: Hypofunction of γ-amino-butyri acid (GABA), hypothesis of noradrenaline 5-serotonin and nutrition metabolism can cause TD disease. Treatlent for TD: (1) Dopamine receptor agonist: The therapeutic effect is not satisfactory, especially for gerontism females. (2) Oxygen free radical scavenger: As represent of vitamin E, it can clear out free radicals and reduce the potential cytotoxic effect of free radicals. (3) Calcium channel blocker: This maybe related to block calcium ions releasing from muscle cells and inhibit muscle convulsion; therefore, it can be used for symptomatic treatment. (4) GABA receptor agonist: It is more effective for the prominent dysmyotonia than dancing slowly symptom. (5) Antipsychotic: There is some therapeutic effect with ciozapine, but the effect will reduce because of the age growing up and the symptom exacerbating. (6) Other therapies: Valproate sodium, cyproheptadine, melatonin, branched chain amino acid, ahalysantinfarctasum, electric acupuncture and injection ad acumen, traditional Chinese drug have a certain effects on TD. Prevention of TD: The serum creatine phosphokinase (CPK) combined with symptoms should be checked regularly so as to early discovery TD. CONCLUSION : (1) Etiology of TD: The hypothesis of dopamine receptor super-sensitivity is denyed; the hypothesis of neuronal degeneration is approved in academic circles; the sex and age is a finding of generally received; but the dopamine and 5-HT receptor gene polymorphism, hypofunction of GABA, noradrenaline, 5-serotonin and nutrition metabolism cannot explain the pathogenesis of TD. (2) Treatment for TD: The therapeutic effect of dopamine receptor agonist is not satisfactory; the oxygen free radical scavenger maybe effective; calcium channel blocker maybe used for symptomatic treatment; GABA receptor agonist maybe more effective for the prominent dysmyotonia than dancing slowly symptom; the consequence of antipsychotic is discrepancy; other therapies maybe use to adjunctive therapies. (3) As far as prevention of TD is concerned, and the serum CPK combined with symptoms should be checked regularly so as to early discovery TD. 展开更多
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部